Pancreatic Alpha-Cells Contribute Together With Beta-Cells to CXCL10 Expression in Type 1 Diabetes
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pancreatic Alpha-Cells Contribute Together With Beta-Cells to CXCL10 Expression in Type 1 Diabetes
Authors
Keywords
-
Journal
Frontiers in Endocrinology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-09-15
DOI
10.3389/fendo.2020.00630
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- miR-409-3p is reduced in plasma and islet immune infiltrates of NOD diabetic mice and is differentially expressed in people with type 1 diabetes
- (2019) Giuliana Ventriglia et al. DIABETOLOGIA
- IL-6 is present in beta and alpha cells in human pancreatic islets: Expression is reduced in subjects with type 1 diabetes
- (2019) Sakthi Rajendran et al. CLINICAL IMMUNOLOGY
- From immunohistological to anatomical alterations of human pancreas in type 1 diabetes: New concepts on the stage
- (2019) Laura Nigi et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Chemokines beyond chemo-attraction: CXCL10 and its significant role in cancer and autoimmunity
- (2018) Nathan Karin et al. CYTOKINE
- Increased Chromogranin A–Positive Hormone-Negative Cells in Chronic Pancreatitis
- (2018) Abu Saleh Md Moin et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes
- (2018) Marcela Brissova et al. Cell Reports
- Conventional and Neo-Antigenic Peptides Presented by β Cells Are Targeted by Circulating Naïve CD8+ T Cells in Type 1 Diabetic and Healthy Donors
- (2018) Sergio Gonzalez-Duque et al. Cell Metabolism
- Lymphocyte-Derived Exosomal MicroRNAs Promote Pancreatic β Cell Death and May Contribute to Type 1 Diabetes Development
- (2018) Claudiane Guay et al. Cell Metabolism
- Alpha cells, the main source of IL-1β in human pancreas
- (2017) Florence Anquetil et al. JOURNAL OF AUTOIMMUNITY
- Regulatory T-cells from pancreatic lymphnodes of patients with type-1 diabetes express increased levels of microRNA miR-125a-5p that limits CCR2 expression
- (2017) Guido Sebastiani et al. Scientific Reports
- Pancreatic β-Cell production of CXCR3 ligands precedes diabetes onset
- (2016) Susan J. Burke et al. BIOFACTORS
- Islet-Expressed CXCL10 Promotes Autoimmune Destruction of Islet Isografts in Mice With Type 1 Diabetes
- (2016) Christine Bender et al. DIABETES
- Expression of Interferon-Stimulated Genes in Insulitic Pancreatic Islets of Patients Recently Diagnosed With Type 1 Diabetes
- (2016) Marcus Lundberg et al. DIABETES
- Islet cell hyperexpression of HLA class I antigens: a defining feature in type 1 diabetes
- (2016) Sarah J. Richardson et al. DIABETOLOGIA
- Single-cell transcriptomes identify human islet cell signatures and reveal cell-type–specific expression changes in type 2 diabetes
- (2016) Nathan Lawlor et al. GENOME RESEARCH
- Insulitis in the pathogenesis of type 1 diabetes
- (2016) Alberto Pugliese PEDIATRIC DIABETES
- Anti-CD3/Anti-CXCL10 Antibody Combination Therapy Induces a Persistent Remission of Type 1 Diabetes in Two Mouse Models
- (2015) Stanley Lasch et al. DIABETES
- Back From the Brink: The Uses of Targeting the CXCL10:CXCR3 Axis in Type 1 Diabetes
- (2015) Dirk Homann DIABETES
- TYK2, a Candidate Gene for Type 1 Diabetes, Modulates Apoptosis and the Innate Immune Response in Human Pancreatic β-Cells
- (2015) Laura Marroqui et al. DIABETES
- Novel Observations From Next-Generation RNA Sequencing of Highly Purified Human Adult and Fetal Islet Cell Subsets
- (2015) David M. Blodgett et al. DIABETES
- Insulitis and characterisation of infiltrating T cells in surgical pancreatic tail resections from patients at onset of type 1 diabetes
- (2015) Lars Krogvold et al. DIABETOLOGIA
- NLRP3 deficiency protects from type 1 diabetes through the regulation of chemotaxis into the pancreatic islets
- (2015) Changyun Hu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CXCR3, CXCL10 and type 1 diabetes
- (2014) Alessandro Antonelli et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Detection of a Low-Grade Enteroviral Infection in the Islets of Langerhans of Living Patients Newly Diagnosed With Type 1 Diabetes
- (2014) Lars Krogvold et al. DIABETES
- Pancreatic biopsy by minimal tail resection in live adult patients at the onset of type 1 diabetes: experiences from the DiViD study
- (2014) Lars Krogvold et al. DIABETOLOGIA
- VEGF-A: The Inductive Angiogenic Factor for Development, Regeneration and Function of Pancreatic Beta Cells
- (2014) Kathy Lui Current Stem Cell Research & Therapy
- Epigenomic plasticity enables human pancreatic α to β cell reprogramming
- (2013) Nuria C. Bramswig et al. JOURNAL OF CLINICAL INVESTIGATION
- The Peri-islet Basement Membrane, a Barrier to Infiltrating Leukocytes in Type 1 Diabetes in Mouse and Human
- (2012) E. Korpos et al. DIABETES
- Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients
- (2012) Ken T. Coppieters et al. JOURNAL OF EXPERIMENTAL MEDICINE
- An IP-10 (CXCL10)-Derived Peptide Inhibits Angiogenesis
- (2012) Cecelia C. Yates-Binder et al. PLoS One
- Small molecule CXCR3 antagonist NIBR2130 has only a limited impact on type 1 diabetes in a virus-induced mouse model
- (2011) S. Christen et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Serum titres of anti-glutamic acid decarboxylase-65 and anti-IA-2 autoantibodies are associated with different immunoregulatory milieu in newly diagnosed type 1 diabetes patients
- (2011) M. Andrade Lima Gabbay et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Transcriptomes of the major human pancreatic cell types
- (2011) C. Dorrell et al. DIABETOLOGIA
- Islet inflammation and CXCL10 in recent-onset type 1 diabetes
- (2010) B. O. Roep et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Expression of chemokines, CXC chemokine ligand 10 (CXCL10) and CXCR3 in the inflamed islets of patients with recent-onset autoimmune type 1 diabetes
- (2010) Sae Uno et al. ENDOCRINE JOURNAL
- CXCL10 Impairs β Cell Function and Viability in Diabetes through TLR4 Signaling
- (2009) Fabienne T. Schulthess et al. Cell Metabolism
- Enterovirus Infection, CXC Chemokine Ligand 10 (CXCL10), and CXCR3 Circuit: A Mechanism of Accelerated -Cell Failure in Fulminant Type 1 Diabetes
- (2009) S. Tanaka et al. DIABETES
- Predominant Expression of CCL2 at the Tumor Site of Prostate Cancer Patients Directs a Selective Loss of Immunological Tolerance to CCL2 That Could Be Amplified in a Beneficial Manner
- (2009) L. Izhak et al. JOURNAL OF IMMUNOLOGY
- Analysis of islet inflammation in human type 1 diabetes
- (2008) A. Willcox et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Serum Th1 (CXCL10) and Th2 (CCL2) chemokine levels in children with newly-diagnosed type 1 diabetes: a longitudinal study.
- (2008) A. Antonelli et al. DIABETIC MEDICINE
- The target cell response to cytokines governs the autoreactive T cell repertoire in the pancreas of NOD mice
- (2008) M. Hultcrantz et al. DIABETOLOGIA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now